Welcome to the ad:tech London multimedia platform. This is a place for brands, agencies, publishers and technology professionals to access video content, news releases, blogs, case studies and reports relating to the UK’s largest digital marketing and media show. We have built this platform to complement the ad:tech exhibition and conference visitor experience so whether you are a brand or agency marketer, media owner advertising professional, technology supplier or member of the press, you will find the site packed with useful content and insight to support your digital marketing and media strategy.
To view Multimedia News Release, go to http://www.multivu.com/players/English/51358-adtech-london-multimedia-platform/
DocuSign, Inc. (DocuSign®) launched its DocuSign Winter ’15 Release, which includes an improved signing experience based on customer feedback from focus groups, usability studies, user testing and more. DocuSign’s new signing experience features both visual and interaction design enhancements that reflect the company’s commitment to customer-centric product innovation, www.docusign.com/docusign-winter-15-release.
To view the Multimedia News Release, go to http://www.multivu.com/players/English/7312253-docusign-winter-15/
Studies show that more than two-thirds of aesthetically-oriented consumers are bothered by submental fullness, or “double chin.” And with social media profile images becoming more important than ever, there is interest in looking one’s best.
Submental fullness due to fat beneath the chin can impact a broad range of both men and women and because the condition can be genetic and resistant to diet and exercise. But there’s KYBELLA®, the first and only FDA-approved injectable treatment that is available by prescription only, that has been proven to improve the appearance of moderate to severe fat beneath the chin by physically destroying fat cells in the treatment area. In two pivotal clinical studies for KYBELLA®, reductions in submental fat volume were observed more frequently in the KYBELLA® treated group of 514 patients compared to the placebo group (508 patients) as measured by both clinician and patient ratings. In addition, visual and emotional impacts of submental fat (happy, bothered, self-conscious, embarrassed, looking older or overweight) were evaluated using a 6-question survey and 79% of 1 and 2-grade composite responders reported satisfaction after 12 weeks post final treatment compared with 33.6% of patients who received placebo.
To view the multimedia release go to:
http://www.multivu.com/players/English/7962051-kybella-injectable-double-chin-treatment-campaign/
BLACK+DECKER™ has joined Habitat for Humanity’s first nationwide cause campaign, Home is the Key (#HomeIsTheKey), in raising awareness throughout April of the critical need for improved access to decent shelter. Funds raised during the campaign will allow Habitat to partner with more families and unlock better, stable futures. BLACK+DECKER understands the significance of calling a place home and is proud to support this important initiative.
“We are thrilled to be part of a movement that will help open more doors to affordable homeownership,” said Allison Nicolaidis, Chief Marketing Officer for Global Tools & Storage at Stanley Black & Decker. “Studies have shown that a stable home plays a key role in positively influencing a family’s education, health and financial opportunities. We feel that the BLACK+DECKER mission of turning the place you live into a home goes hand-in-hand with this campaign.”
To view the multimedia release go to:
https://www.multivu.com/players/English/8005954-black-decker-habitat-for-humanity/
